S2303: phase II/III trial of paclitaxel + ramucirumab ± nivolumab in gastric and esophageal adenocarcinoma (PARAMUNE)

Authors

Institutions

Publication Details

Journal
Future Oncology
Published
2025-03-28
DOI
https://doi.org/10.1080/14796694.2025.2485020
Citations
2
Primary Topic
Gastric Cancer Management and Outcomes
Type
article
Field-Weighted Citation Impact
3.04

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

S2303: phase II/III trial of paclitaxel + ramucirumab ± nivolumab in gastric and esophageal adenocarcinoma (PARAMUNE)

Philip A. Philip, Paul E. Oberstein, Zev A. Wainberg, E. Gabriela Chiorean et al.
2 citations
Future Oncology
Gastric Cancer Management and Outcomes
3.04
article

S2303: phase II/III trial of paclitaxel + ramucirumab ± nivolumab in gastric and esophageal adenocarcinoma (PARAMUNE)

Philip A. Philip, Paul E. Oberstein, Zev A. Wainberg, E. Gabriela Chiorean, Colmar Figueroa-Moseley, Dan G. Duda, Flavio G. Rocha, Maheswari Senthil, Katherine A. Guthrie, Anwaar Saeed, Rachael A. Safyan, Robin Park, Sarah Colby, Syma Iqbal, Riha Vaidya, Rajiv Agarwal, Joseph M. Unger
article en
2 citations

Abstract

No abstract available for this paper.
Future OncologyVol. 21(11)
University of Southern California (US), Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa (ZA), Oregon Health & Science University (US), Wayne State University (US), Breast Cancer Research Foundation (US), Vanderbilt University (US), University of Washington (US), University of California, Irvine (US), Henry Ford Hospital (US), Moffitt Cancer Center (US), NYU Langone Health (US), Massachusetts General Hospital (US), Fred Hutch Cancer Center (US), USC Norris Comprehensive Cancer Center (US), UPMC Hillman Cancer Center (US), Vanderbilt-Ingram Cancer Center, NYU Langone’s Laura and Isaac Perlmutter Cancer Center, UC Davis Comprehensive Cancer Center, University of California, Davis (US)
National Institutes of Health, National Cancer Institute
Zero hunger
Openalex Percentile: Top 10%
Gastric Cancer Management and Outcomes
3.04
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.